Vycor Medical (VYCO) Operating Expenses (2010 - 2026)

Vycor Medical (VYCO) has reported Operating Expenses for 17 consecutive years, with $337594.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 7.29% year-over-year to $337594.0 in Q2 2026; TTM through Jun 2026 was $1.5 million, a 2.93% decrease from a year earlier, with the FY2025 full-year figure at $1.5 million, up 6.67% from the prior year.
• Operating Expenses was $337594.0 for Q2 2026 at Vycor Medical, up from $329345.0 in the prior quarter.
• Over five years, Operating Expenses peaked at $419847.0 in Q3 2025 and troughed at $296987.0 in Q1 2023.
• A 5-year average of $349451.6 and a median of $350694.0 in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses fell 29.7% in 2022 and rose 28.98% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $325309.0 in 2022, then rose by 1.53% to $330285.0 in 2023, then advanced by 14.46% to $378038.0 in 2024, then declined by 1.62% to $371895.0 in 2025, then slipped by 9.22% to $337594.0 in 2026.
• The last three Operating Expenses figures came in at $337594.0 (Q2 2026), $329345.0 (Q1 2026), and $371895.0 (Q4 2025), per Business Quant data.